About 1 in 3 Americans have lost someone to a drug overdose, new study finds
Front lines of America's fentanyl crisis On the front lines of America's fentanyl crisis 04:24 About one in three Americans ...
Tag: Study
Is your gym overflowing? A new study shows gym use is nearly double pre-pandemic levels and Gen Z is driving the trend
Do you spend a lot of time at the gym lately waiting for an empty squat rack? Or maybe you’re ...
Some of the most talented, high-ranking workers at Apple, Microsoft, and SpaceX jumped ship after return-to-office mandates, new study reveals
The focus of return-to-office discussions have long focused on the individuals. Why might workers prefer to stay home? Which age ...
Goldman Sachs and American Express are among the leading companies for working parents in 2024, new study shows
Vadym Buinov | Moment | Getty ImagesWorking parents, guardians or caretakers know the challenge of striking the delicate balance between ...
Nearly all stablecoin transactions are from bots and large-scale traders, not genuine users, study says
More than 90% of stablecoin transaction volumes aren’t coming from genuine users, according to a new metric co-developed by Visa ...
Eating more avocados could lower risk of Type 2 diabetes in women, study says
Eating more avocados could help women stave off Type 2 diabetes, study says Eating more avocados could help women stave ...
This is the level where the 10-year Treasury yield becomes a ‘clear problem’ for stocks, Goldman study shows
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., April 29, 2024. Brendan ...
More women are falling behind on breast cancer screenings, study shows
CDC study says not enough women are current with mammograms CDC study says not enough women are current with mammograms ...
Ad transparency tools are ‘major disappointment’ ahead of election, new study shows
Heading into the 2024 election in the U.S. and major political contests around the world, internet companies are unprepared for ...
ALS drug will be pulled from US market after study showed patients didn’t benefit
The maker of a drug for Lou Gehrig’s disease that recently failed in a large study said Thursday it will pull the ...
